{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:52:36Z","timestamp":1711155156507},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00106-024-01443-w","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T21:22:41Z","timestamp":1710278561000},"page":"231-241","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Schwierig zu behandelnde chronische Rhinosinusitis\u00a0\u2013 wenn die Standardtherapie nicht wirkt und Biologika nicht zur Verf\u00fcgung stehen","Difficult-to-treat chronic rhinosinusitis\u2014when the\u00a0standard treatment is not effective and biologics are not available"],"prefix":"10.1007","volume":"72","author":[{"given":"Robert","family":"B\u00f6scke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"1443_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","volume":"103","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens\u00a0WJ, Lund\u00a0VJ, Hopkins\u00a0C et\u00a0al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinol\u00a0J 103:1\u2013464. https:\/\/doi.org\/10.4193\/Rhin20.600","journal-title":"Rhinol J"},{"key":"1443_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","volume":"11","author":"RR Orlandi","year":"2021","unstructured":"Orlandi\u00a0RR, Kingdom\u00a0TT, Smith\u00a0TL et\u00a0al (2021) International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol 11:213\u2013739. https:\/\/doi.org\/10.1002\/alr.22741","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR3","series-title":"AWMF-Register-Nr 017\/049 und 053-012","first-page":"1","volume-title":"S2k-Leitlinie Rhinosinusitis","author":"BA Stuck","year":"2017","unstructured":"Stuck\u00a0BA, Popert\u00a0U, Beule\u00a0AG (2017) S2k-Leitlinie Rhinosinusitis. AWMF-Register-Nr 017\/049 und 053-012, S\u00a01\u201394"},{"key":"1443_CR4","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jaci.2018.03.004","volume":"141","author":"C Bachert","year":"2018","unstructured":"Bachert\u00a0C, Zhang\u00a0N, Hellings\u00a0PW, Bousquet\u00a0J (2018) Endotype-driven care pathways in patients with chronic rhinosinusitis. J\u00a0Allergy Clin Immunol 141:1543\u20131551. https:\/\/doi.org\/10.1016\/j.jaci.2018.03.004","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/all.15074","volume":"77","author":"A Kato","year":"2022","unstructured":"Kato\u00a0A, Peters\u00a0AT, Stevens\u00a0WW et\u00a0al (2022) Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy Eur J Allergy Clin Immunol 77:812\u2013826. https:\/\/doi.org\/10.1111\/all.15074","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"1443_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaci.2022.12.826","volume":"151","author":"ME Kotas","year":"2023","unstructured":"Kotas\u00a0ME, Patel\u00a0NN, Cope\u00a0EK et\u00a0al (2023) IL-13-associated epithelial remodeling correlates with clinical severity in nasal polyposis. J\u00a0Allergy Clin Immunol 151:1277\u20131285. https:\/\/doi.org\/10.1016\/j.jaci.2022.12.826","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jaci.2020.04.040","volume":"146","author":"T Delemarre","year":"2020","unstructured":"Delemarre\u00a0T, Holtappels\u00a0G, De Ruyck\u00a0N et\u00a0al (2020) Type\u00a02 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype. J\u00a0Allergy Clin Immunol 146:337\u2013343.e6. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.040","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/all.13599","volume":"74","author":"ML Kowalski","year":"2019","unstructured":"Kowalski\u00a0ML, Agache\u00a0I, Bavbek\u00a0S et\u00a0al (2019) Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)\u2014a EAACI position paper. Allergy Eur J Allergy Clin Immunol 74:28\u201339. https:\/\/doi.org\/10.1111\/all.13599","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","volume":"7","author":"WW Stevens","year":"2019","unstructured":"Stevens\u00a0WW, Peters\u00a0AT, Tan\u00a0BK et\u00a0al (2019) Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J\u00a0Allergy Clin Immunol Pract 7:2812\u20132820.e3. https:\/\/doi.org\/10.1016\/j.jaip.2019.05.009","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1443_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/JAA.S372598","volume":"16","author":"JF Maspero","year":"2023","unstructured":"Maspero\u00a0JF, Khan\u00a0AH, Philpott\u00a0C et\u00a0al (2023) Health-related quality of life impairment among patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 trial. J\u00a0Asthma Allergy 16:323\u2013332. https:\/\/doi.org\/10.2147\/JAA.S372598","journal-title":"J Asthma Allergy"},{"key":"1443_CR11","unstructured":"Braun V (2019) First-line-therapie. In: Pschyrembel. https:\/\/www.pschyrembel.de\/First-line-Therapie\/K0RM7. Zugegriffen: 3. Febr. 2024"},{"key":"1443_CR12","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, De Corso E, Backer V, Bjermer L (2024) EPOS2020\/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinol\u00a0J: 1\u201312","DOI":"10.4193\/Rhin23.415"},{"key":"1443_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/00002018-200023010-00002","volume":"23","author":"BJ Lipworth","year":"2000","unstructured":"Lipworth\u00a0BJ, Jackson\u00a0CM (2000) Safety of inhaled and intranasal corticosteroids. Lessons for the new millennium. Drug Saf 23:11\u201333. https:\/\/doi.org\/10.2165\/00002018-200023010-00002","journal-title":"Drug Saf"},{"key":"1443_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/lary.28152","volume":"130","author":"KM Phillips","year":"2020","unstructured":"Phillips\u00a0KM, Hoehle\u00a0LP, Caradonna\u00a0DS et\u00a0al (2020) Intranasal corticosteroids and saline: usage and adherence in chronic rhinosinusitis patients. Laryngoscope 130:852\u2013856. https:\/\/doi.org\/10.1002\/lary.28152","journal-title":"Laryngoscope"},{"key":"1443_CR15","first-page":"69","volume":"37","author":"R Weber","year":"1999","unstructured":"Weber\u00a0R, Keerl\u00a0R, Radziwill\u00a0R et\u00a0al (1999) Videoendoscopic analysis of nasal steroid distribution. Rhinology 37:69\u201373","journal-title":"Rhinology"},{"key":"1443_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/alr.22093","volume":"8","author":"RJ Harvey","year":"2018","unstructured":"Harvey\u00a0RJ, Snidvongs\u00a0K, Kalish\u00a0LH et\u00a0al (2018) Corticosteroid nasal irrigations are more effective than simple sprays in a\u00a0randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery. Int Forum Allergy Rhinol 8:461\u2013470. https:\/\/doi.org\/10.1002\/alr.22093","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","volume":"3","author":"PG Djupesland","year":"2013","unstructured":"Djupesland\u00a0PG (2013) Nasal drug delivery devices: characteristics and performance in a\u00a0clinical perspective\u2011a review. Drug Deliv Transl Res 3:42\u201362. https:\/\/doi.org\/10.1007\/s13346-012-0108-9","journal-title":"Drug Deliv Transl Res"},{"key":"1443_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jaci.2018.10.037","volume":"143","author":"W Fokkens","year":"2019","unstructured":"Fokkens\u00a0W, Reitsma\u00a0S (2019) New delivery forms of nasal corticosteroids. J\u00a0Allergy Clin Immunol 143:87\u201388. https:\/\/doi.org\/10.1016\/j.jaci.2018.10.037","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0074991","volume":"8","author":"W M\u00f6ller","year":"2013","unstructured":"M\u00f6ller\u00a0W, Schuschnig\u00a0U, Celik\u00a0G et\u00a0al (2013) Topical drug delivery in chronic rhinosinusitis patients before and after sinus surgery using pulsating aerosols. PLoS One 8:1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0074991","journal-title":"PLoS One"},{"key":"1443_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103605","author":"C Calvo-Henriquez","year":"2023","unstructured":"Calvo-Henriquez\u00a0C, Viera-Artiles\u00a0J, Rodriguez-Iglesias\u00a0M et\u00a0al (2023) The role of corticosteroid nasal irrigations in the management of chronic rhinosinusitis: a\u00a0state-of-the-art systematic review. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm12103605","journal-title":"J Clin Med"},{"key":"1443_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.anai.2022.09.008","volume":"130","author":"JA Bernstein","year":"2023","unstructured":"Bernstein\u00a0JA, White\u00a0AA, Han\u00a0JK et\u00a0al (2023) Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitis. Ann Allergy Asthma Immunol 130:46\u201357. https:\/\/doi.org\/10.1016\/j.anai.2022.09.008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1443_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.otohns.2009.09.006","volume":"141","author":"RJ Harvey","year":"2009","unstructured":"Harvey\u00a0RJ, Debnath\u00a0N, Srubiski\u00a0A et\u00a0al (2009) Fluid residuals and drug exposure in nasal irrigation. Otolaryngol Head Neck Surg 141:757\u2013761. https:\/\/doi.org\/10.1016\/j.otohns.2009.09.006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1443_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/alr.23227","volume":"i","author":"BRC Silva","year":"2023","unstructured":"Silva\u00a0BRC, Tyler\u00a0MA, Ma\u00a0Y et\u00a0al (2023) Incidence of hypocortisolism with long-term budesonide irrigation for chronic rhinosinusitis. Int Forum Allergy Rhinol i:1\u20138. https:\/\/doi.org\/10.1002\/alr.23227","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/alr.22141","volume":"8","author":"JN Palmer","year":"2018","unstructured":"Palmer\u00a0JN, Jacobson\u00a0KW, Messina\u00a0JC et\u00a0al (2018) EXHANCE-12: 1\u2011year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis. Int Forum Allergy Rhinol 8:869\u2013876. https:\/\/doi.org\/10.1002\/alr.22141","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1945892418810281","volume":"33","author":"R Sindwani","year":"2019","unstructured":"Sindwani\u00a0R, Han\u00a0JK, Soteres\u00a0DF et\u00a0al (2019) NAVIGATE I:\u00a0randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps. am j rhinol allergy 33:69\u201382. https:\/\/doi.org\/10.1177\/1945892418810281","journal-title":"am j rhinol allergy"},{"key":"1443_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaci.2018.06.010","volume":"143","author":"DA Leopold","year":"2019","unstructured":"Leopold\u00a0DA, Elkayam\u00a0D, Messina\u00a0JC et\u00a0al (2019) NAVIGATE II: randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis. J\u00a0Allergy Clin Immunol 143:126\u2013134.e5. https:\/\/doi.org\/10.1016\/j.jaci.2018.06.010","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4193\/Rhin19.124","volume":"58","author":"MR Sher","year":"2020","unstructured":"Sher\u00a0MR, Steven\u00a0GC, Romett\u00a0JL et\u00a0al (2020) EXHANCE-3: a\u00a0cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps. Rhinology 58:25\u201335. https:\/\/doi.org\/10.4193\/Rhin19.124","journal-title":"Rhinology"},{"key":"1443_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/19458924211033214","volume":"36","author":"D Wu","year":"2022","unstructured":"Wu\u00a0D, Huang\u00a0T, Wei\u00a0Y (2022) Effects of fluticasone exhalation delivery system in patients with chronic rhinosinusitis with nasal polyps: a\u00a0systematic review. Am J Rhinol Allergy 36:176\u2013184. https:\/\/doi.org\/10.1177\/19458924211033214","journal-title":"Am J Rhinol Allergy"},{"key":"1443_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph16020135","volume":"16","author":"L Leclerc","year":"2023","unstructured":"Leclerc\u00a0L, Pr\u00e9v\u00f4t\u00a0N, Hodin\u00a0S et\u00a0al (2023) Acoustic aerosol delivery: assessing of various nasal delivery techniques and medical devices on intrasinus drug deposition. Pharmaceuticals 16:1\u201315. https:\/\/doi.org\/10.3390\/ph16020135","journal-title":"Pharmaceuticals"},{"key":"1443_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4193\/Rhin18.010","volume":"57","author":"G Reychler","year":"2019","unstructured":"Reychler\u00a0G, Domachowski\u00a0C, Latiers\u00a0AC et\u00a0al (2019) Clinical efficacy of intranasal drug delivery by nebulization in chronic rhinosinusitis: a\u00a0systematic review. Rhinology 57:82\u201393. https:\/\/doi.org\/10.4193\/Rhin18.010","journal-title":"Rhinology"},{"key":"1443_CR31","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jaci.2014.10.018","volume":"135","author":"C Wang","year":"2015","unstructured":"Wang\u00a0C, Lou\u00a0H, Wang\u00a0X et\u00a0al (2015) Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps. J\u00a0Allergy Clin Immunol 135:922\u2013929.e6. https:\/\/doi.org\/10.1016\/j.jaci.2014.10.018","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/alr.21044","volume":"2","author":"JK Han","year":"2012","unstructured":"Han\u00a0JK, Marple\u00a0BF, Smith\u00a0TL et\u00a0al (2012) Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol 2:271\u2013279. https:\/\/doi.org\/10.1002\/alr.21044","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/alr.22238","volume":"9","author":"A Singh","year":"2019","unstructured":"Singh\u00a0A, Luong\u00a0AU, Fong\u00a0KJ et\u00a0al (2019) Bioabsorbable steroid-releasing implants in the frontal sinus ostia: a\u00a0pooled analysis. Int Forum Allergy Rhinol 9:131\u2013139. https:\/\/doi.org\/10.1002\/alr.22238","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/1945892419850924","volume":"33","author":"JP Stolovitzky","year":"2019","unstructured":"Stolovitzky\u00a0JP, Kern\u00a0RC, Han\u00a0JK et\u00a0al (2019) In-office placement of mometasone furoate sinus implants for recurrent nasal polyps: a\u00a0pooled analysis. am j rhinol allergy 33:545\u2013558. https:\/\/doi.org\/10.1177\/1945892419850924","journal-title":"am j rhinol allergy"},{"key":"1443_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/alr.22883","volume":"12","author":"A Cervin","year":"2022","unstructured":"Cervin\u00a0A, Rimmer\u00a0J, Wrobel\u00a0A et\u00a0al (2022) Long-acting implantable corticosteroid matrix for chronic rhinosinusitis: results of LANTERN Phase\u00a02 randomized controlled study. Int Forum Allergy Rhinol 12:147\u2013159. https:\/\/doi.org\/10.1002\/alr.22883","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.21053\/ceo.2022.01718","volume":"16","author":"SH Hwang","year":"2023","unstructured":"Hwang\u00a0SH, Kim\u00a0SW, Basurrah\u00a0MA, Kim\u00a0DH (2023) Efficacy of steroid-impregnated spacers after endoscopic sinus surgery in chronic rhinosinusitis: a\u00a0systematic review and meta-analysis. Clin Exp Otorhinolaryngol 16:148\u2013158. https:\/\/doi.org\/10.21053\/ceo.2022.01718","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"1443_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/AJO-21-45","volume":"5","author":"N Hui","year":"2022","unstructured":"Hui\u00a0N, Yii\u00a0N, Robinson\u00a0D (2022) Xylitol nasal preparations in sinonasal disease: a\u00a0literature review and meta-analysis. Aust J Otolaryngol 5:1\u20138. https:\/\/doi.org\/10.21037\/AJO-21-45","journal-title":"Aust J Otolaryngol"},{"key":"1443_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00302","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann\u00a0P, Ziesenitz\u00a0VC, Curtis\u00a0N, Ritz\u00a0N (2018) The immunomodulatory effects of macrolides\u2011a systematic review of the underlying mechanisms. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00302","journal-title":"Front Immunol"},{"key":"1443_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1124\/PHARMREV.121.000300","volume":"73","author":"JA Kricker","year":"2021","unstructured":"Kricker\u00a0JA, Page\u00a0CP, Gardarsson\u00a0FR et\u00a0al (2021) Nonantimicrobial actions of macrolides: overview and perspectives for future development. Pharmacol Rev 73:233\u2013262. https:\/\/doi.org\/10.1124\/PHARMREV.121.000300","journal-title":"Pharmacol Rev"},{"key":"1443_CR40","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/lary.27865","volume":"129","author":"K Seresirikachorn","year":"2019","unstructured":"Seresirikachorn\u00a0K, Suwanparin\u00a0N, Srisunthornphanich\u00a0C et\u00a0al (2019) Factors of success of low-dose macrolides in chronic sinusitis: systematic review and meta-analysis. Laryngoscope 129:1510\u20131519. https:\/\/doi.org\/10.1002\/lary.27865","journal-title":"Laryngoscope"},{"key":"1443_CR41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/alr.22281","volume":"9","author":"Z Huang","year":"2019","unstructured":"Huang\u00a0Z, Zhou\u00a0B (2019) Clarithromycin for the treatment of adult chronic rhinosinusitis: a\u00a0systematic review and meta-analysis. Int Forum Allergy Rhinol 9:545\u2013555. https:\/\/doi.org\/10.1002\/alr.22281","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.461","volume-title":"Systematic review and meta-analysis: macrolide in the treatment of chronic rhinosinusitis after endoscopic sinus surgery","author":"F Shu","year":"2023","unstructured":"Shu\u00a0F, Li\u00a0CX, Zhang\u00a0F et\u00a0al (2023) Systematic review and meta-analysis: macrolide in the treatment of chronic rhinosinusitis after endoscopic sinus surgery. Otolaryngol\u2212Head Neck Surg, United States https:\/\/doi.org\/10.1002\/ohn.461"},{"key":"1443_CR43","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.21037\/jtd.2018.10.41","volume":"10","author":"S Shen","year":"2018","unstructured":"Shen\u00a0S, Lou\u00a0H, Wang\u00a0C, Zhang\u00a0L (2018) Macrolide antibiotics in the treatment of chronic rhinosinusitis: evidence from a\u00a0meta-analysis. J\u00a0Thorac Dis 10:5913\u20135923. https:\/\/doi.org\/10.21037\/jtd.2018.10.41","journal-title":"J Thorac Dis"},{"key":"1443_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin19.325","volume":"58","author":"CF Lin","year":"2020","unstructured":"Lin\u00a0CF, Wang\u00a0MC, Merton\u00a0AT et\u00a0al (2020) Add-on effect of clarithromycin to oral steroids as post-operative therapy for chronic rhinosinusitis with nasal polyps: a\u00a0randomised controlled trial. Rhinology 58:1\u20139. https:\/\/doi.org\/10.4193\/Rhin19.325","journal-title":"Rhinology"},{"key":"1443_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4193\/Rhin17.049","volume":"56","author":"GM Oakley","year":"2018","unstructured":"Oakley\u00a0GM, Christensen\u00a0JM, Sacks\u00a0R et\u00a0al (2018) Characteristics of macrolide responders in persistent post-surgical rhinosinusitis. Rhinology 56:111\u2013117. https:\/\/doi.org\/10.4193\/Rhin17.049","journal-title":"Rhinology"},{"key":"1443_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4193\/Rhin17.226","volume":"57","author":"M Zeng","year":"2019","unstructured":"Zeng\u00a0M, Wang\u00a0H, Liao\u00a0B et\u00a0al (2019) Comparison of efficacy of fluticasone propionate versus clarithromycin for postoperative treatment of different phenotypic chronic rhinosinusitis: a\u00a0randomized controlled trial. Rhinology 57:101\u2013109. https:\/\/doi.org\/10.4193\/Rhin17.226","journal-title":"Rhinology"},{"key":"1443_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/01.mlg.0000191560.53555.08","volume":"116","author":"B Wallwork","year":"2006","unstructured":"Wallwork\u00a0B, Coman\u00a0W, Mackay-Sim\u00a0A et\u00a0al (2006) A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116:189\u2013193. https:\/\/doi.org\/10.1097\/01.mlg.0000191560.53555.08","journal-title":"Laryngoscope"},{"key":"1443_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000027731","volume":"62","author":"H Suzuki","year":"2000","unstructured":"Suzuki\u00a0H, Ikeda\u00a0K, Honma\u00a0R et\u00a0al (2000) Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL 62:121\u2013127. https:\/\/doi.org\/10.1159\/000027731","journal-title":"ORL"},{"key":"1443_CR49","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/lary.25052","volume":"125","author":"BR Haxel","year":"2015","unstructured":"Haxel\u00a0BR, Clemens\u00a0M, Karaiskaki\u00a0N et\u00a0al (2015) Controlled trial for long-term low-dose erythromycin after sinus surgery for chronic rhinosinusitis. Laryngoscope 125:1048\u20131055. https:\/\/doi.org\/10.1002\/lary.25052","journal-title":"Laryngoscope"},{"key":"1443_CR50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4193\/Rhin20.649","volume":"59","author":"K Seresirikachorn","year":"2021","unstructured":"Seresirikachorn\u00a0K, Kerr\u00a0SJ, Aeumjaturapat\u00a0S et\u00a0al (2021) Predictive factors for identifying macrolide responder in treating chronic rhinosinusitis*. Rhinology 59:284\u2013291. https:\/\/doi.org\/10.4193\/Rhin20.649","journal-title":"Rhinology"},{"key":"1443_CR51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/alr.22691","volume":"11","author":"A Maniakas","year":"2021","unstructured":"Maniakas\u00a0A, Asmar\u00a0MH, Renteria\u00a0AE et\u00a0al (2021) Azithromycin in high-risk, refractory chronic rhinosinusitus after endoscopic sinus surgery and corticosteroid irrigations: a\u00a0double-blind, randomized, placebo-controlled trial. Int Forum Allergy Rhinol 11:747\u2013754. https:\/\/doi.org\/10.1002\/alr.22691","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.071","volume":"58","author":"IS de Oliveira","year":"2020","unstructured":"de Oliveira\u00a0IS, Guimaraes\u00a0AF, P\u00eagas\u00a0GRA et\u00a0al (2020) Azithromycin for chronic eosinophilic rhinosinusitis with nasal polyp: a\u00a0placebo-controlled trial. Rhinology 58:1\u20138. https:\/\/doi.org\/10.4193\/Rhin20.071","journal-title":"Rhinology"},{"key":"1443_CR53","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","volume":"125","author":"T Van Zele","year":"2010","unstructured":"Van Zele\u00a0T, Gevaert\u00a0P, Holtappels\u00a0G et\u00a0al (2010) Oral steroids and doxycycline: two different approaches to treat nasal polyps. J\u00a0Allergy Clin Immunol 125:1069\u20131076. https:\/\/doi.org\/10.1016\/j.jaci.2010.02.020","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4193\/Rhino16.314","volume":"55","author":"E De Schryver","year":"2017","unstructured":"De Schryver\u00a0E, Derycke\u00a0L, Calus\u00a0L et\u00a0al (2017) The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps. Rhinology 55:152\u2013160. https:\/\/doi.org\/10.4193\/Rhino16.314","journal-title":"Rhinology"},{"key":"1443_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4193\/Rhino15.291","volume":"55","author":"AC Pinto Bezerra Soter","year":"2017","unstructured":"Pinto Bezerra Soter\u00a0AC, Pinto Bezerra\u00a0TF, Pezato\u00a0R et\u00a0al (2017) Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps. Rhinology 55:175\u2013180. https:\/\/doi.org\/10.4193\/Rhino15.291","journal-title":"Rhinology"},{"key":"1443_CR56","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/19458924231154066","volume":"37","author":"M Nabavi","year":"2023","unstructured":"Nabavi\u00a0M, Arshi\u00a0S, Bemanian\u00a0MH et\u00a0al (2023) Doxycycline improves quality of life and anosmia in chronic rhinosinusitis with nasal polyposis: a\u00a0randomized controlled trial. Am J Rhinol Allergy 37:384\u2013390. https:\/\/doi.org\/10.1177\/19458924231154066","journal-title":"Am J Rhinol Allergy"},{"key":"1443_CR57","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.amjoto.2019.03.004","volume":"40","author":"AK Parasher","year":"2019","unstructured":"Parasher\u00a0AK, Kidwai\u00a0SM, Konuthula\u00a0N et\u00a0al (2019) The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps. Am J Otolaryngol Head Neck Med Surg 40:467\u2013472. https:\/\/doi.org\/10.1016\/j.amjoto.2019.03.004","journal-title":"Am J Otolaryngol Head Neck Med Surg"},{"key":"1443_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-023-01378-8","author":"RK Weber","year":"2023","unstructured":"Weber\u00a0RK, Hildenbrand\u00a0T, K\u00fchnel\u00a0T et\u00a0al (2023) \u201eRadikale\u201c vs. \u201efunktionelle\u201c Chirurgie der Nasennebenh\u00f6hlen \u2013 ein Widerspruch? HNO. https:\/\/doi.org\/10.1007\/s00106-023-01378-8","journal-title":"HNO"},{"key":"1443_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4193\/Rhino16.023","volume":"54","author":"L Rudmik","year":"2016","unstructured":"Rudmik\u00a0L, Soler\u00a0ZM, Hopkins\u00a0C et\u00a0al (2016) Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: A\u00a0RAND\/UCLA appropriateness study. Rhinology 54:117\u2013128. https:\/\/doi.org\/10.4193\/Rhino16.023","journal-title":"Rhinology"},{"key":"1443_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/alr.21079","volume":"3","author":"MR Gore","year":"2013","unstructured":"Gore\u00a0MR, Ebert\u00a0CS, Zanation\u00a0AM, Senior\u00a0BA (2013) Beyond the \u201ccentral sinus\u201d: Radiographic findings in patients undergoing revision functional endoscopic sinus surgery. Int Forum Allergy Rhinol 3:139\u2013146. https:\/\/doi.org\/10.1002\/alr.21079","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/lary.24858","volume":"125","author":"A Bassiouni","year":"2015","unstructured":"Bassiouni\u00a0A, Chen\u00a0PG, Naidoo\u00a0Y, Wormald\u00a0PJ (2015) Clinical significance of middle turbinate lateralization after endoscopic sinus surgery. Laryngoscope 125:36\u201341. https:\/\/doi.org\/10.1002\/lary.24858","journal-title":"Laryngoscope"},{"key":"1443_CR62","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/lary.22461","volume":"122","author":"A Bassiouni","year":"2012","unstructured":"Bassiouni\u00a0A, Naidoo\u00a0Y, Wormald\u00a0PJ (2012) When FESS fails: the inflammatory load hypothesis in refractory chronic rhinosinusitis. Laryngoscope 122:460\u2013466. https:\/\/doi.org\/10.1002\/lary.22461","journal-title":"Laryngoscope"},{"key":"1443_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/alr.23035","volume":"13","author":"ES Longino","year":"2023","unstructured":"Longino\u00a0ES, Labby\u00a0AB, Wu\u00a0J et\u00a0al (2023) Association of cytokine profile with prior treatment failure and revision surgery in chronic rhinosinusitis. Int Forum Allergy Rhinol 13:5\u201314. https:\/\/doi.org\/10.1002\/alr.23035","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR64","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jaci.2022.02.029","volume":"150","author":"J Bai","year":"2022","unstructured":"Bai\u00a0J, Huang\u00a0JH, Price\u00a0CPE et\u00a0al (2022) Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps. J\u00a0Allergy Clin Immunol 150:352\u2013361.e7. https:\/\/doi.org\/10.1016\/j.jaci.2022.02.029","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR65","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/alr.21739","volume":"6","author":"DK Morrissey","year":"2016","unstructured":"Morrissey\u00a0DK, Bassiouni\u00a0A, Psaltis\u00a0AJ et\u00a0al (2016) Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis. Int Forum Allergy Rhinol 6:820\u2013825. https:\/\/doi.org\/10.1002\/alr.21739","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR66","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/lary.27815","volume":"129","author":"S Alsharif","year":"2019","unstructured":"Alsharif\u00a0S, Jonstam\u00a0K, van Zele\u00a0T et\u00a0al (2019) Endoscopic sinus surgery for type\u20112 CRS wNP: an endotype-based retrospective study. Laryngoscope 129:1286\u20131292. https:\/\/doi.org\/10.1002\/lary.27815","journal-title":"Laryngoscope"},{"key":"1443_CR67","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/all.14550","volume":"76","author":"K Jonstam","year":"2021","unstructured":"Jonstam\u00a0K, Alsharif\u00a0S, Bogaert\u00a0S et\u00a0al (2021) Extent of inflammation in severe nasal polyposis and effect of sinus surgery on inflammation. Allergy Eur J Allergy Clin Immunol 76:933\u2013936. https:\/\/doi.org\/10.1111\/all.14550","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"1443_CR68","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1007\/s00405-022-07470-z","volume":"279","author":"SC Gomes","year":"2022","unstructured":"Gomes\u00a0SC, Cavaliere\u00a0C, Masieri\u00a0S et\u00a0al (2022) Reboot surgery for chronic rhinosinusitis with nasal polyposis: recurrence and smell kinetics. Eur Arch Otorhinolaryngol 279:5691\u20135699. https:\/\/doi.org\/10.1007\/s00405-022-07470-z","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1443_CR69","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/lary.30422","volume":"133","author":"F Pirola","year":"2023","unstructured":"Pirola\u00a0F, Pace\u00a0GM, Giombi\u00a0F et\u00a0al (2023) Outcomes of non-mucosa sparing endoscopic sinus surgery (partial reboot) in refractory chronic rhinosinusitis with nasal polyposis: an academic hospital experience. Laryngoscope 133:1584\u20131589. https:\/\/doi.org\/10.1002\/lary.30422","journal-title":"Laryngoscope"},{"key":"1443_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23178","author":"SP Ramkumar","year":"2023","unstructured":"Ramkumar\u00a0SP, Marks\u00a0L, Lal\u00a0D, Marino\u00a0MJ (2023) Outcomes of limited versus extensive surgery for chronic rhinosinusitis: a\u00a0systematic review and meta-analysis. Int Forum Allergy Rhinol. https:\/\/doi.org\/10.1002\/alr.23178","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR71","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2213-2600(21)00457-4","volume":"10","author":"ES Lourijsen","year":"2022","unstructured":"Lourijsen\u00a0ES, Reitsma\u00a0S, Vleming\u00a0M et\u00a0al (2022) Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a\u00a0multicentre, randomised, controlled trial. Lancet Respir Med 10:337\u2013346. https:\/\/doi.org\/10.1016\/S2213-2600(21)00457-4","journal-title":"Lancet Respir Med"},{"key":"1443_CR72","doi-asserted-by":"publisher","first-page":"CD011991","DOI":"10.1002\/14651858.CD011991.pub2","volume":"4","author":"K Head","year":"2016","unstructured":"Head\u00a0K, Chong\u00a0LY, Hopkins\u00a0C et\u00a0al (2016) Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev 4:CD11991. https:\/\/doi.org\/10.1002\/14651858.CD011991.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1443_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","volume":"10","author":"V Hox","year":"2020","unstructured":"Hox\u00a0V, Lourijsen\u00a0E, Jordens\u00a0A et\u00a0al (2020) Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy 10:1\u201327. https:\/\/doi.org\/10.1186\/s13601-019-0303-6","journal-title":"Clin Transl Allergy"},{"key":"1443_CR74","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/alr.22428","volume":"9","author":"DK Chu","year":"2019","unstructured":"Chu\u00a0DK, Lee\u00a0DJ, Lee\u00a0KM et\u00a0al (2019) Benefits and harms of aspirin desensitization for aspirin-exacerbated respiratory disease: a\u00a0systematic review and meta-analysis. Int Forum Allergy Rhinol 9:1409\u20131419. https:\/\/doi.org\/10.1002\/alr.22428","journal-title":"Int Forum Allergy Rhinol"},{"key":"1443_CR75","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","volume":"149","author":"P Oykhman","year":"2022","unstructured":"Oykhman\u00a0P, Paramo\u00a0FA, Bousquet\u00a0J et\u00a0al (2022) Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a\u00a0systematic review and network meta-analysis. J\u00a0Allergy Clin Immunol 149:1286\u20131295. https:\/\/doi.org\/10.1016\/j.jaci.2021.09.009","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR76","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/lary.26989","volume":"128","author":"L Van Gerven","year":"2018","unstructured":"Van Gerven\u00a0L, Langdon\u00a0C, Cordero\u00a0A et\u00a0al (2018) Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps. Laryngoscope 128:1743\u20131751. https:\/\/doi.org\/10.1002\/lary.26989","journal-title":"Laryngoscope"},{"key":"1443_CR77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000499134","volume":"179","author":"G Stryjewska-Makuch","year":"2019","unstructured":"Stryjewska-Makuch\u00a0G, Humeniuk-Arasiewicz\u00a0M, Jura-Szo\u0142tys\u00a0E, Gl\u00fcck\u00a0J (2019) The effect of antileukotrienes on the results of postoperative treatment of paranasal sinuses in patients with non-steroidal anti-inflammatory drug-exacerbated respiratory disease. Int Arch Allergy Immunol 179:281\u2013289. https:\/\/doi.org\/10.1159\/000499134","journal-title":"Int Arch Allergy Immunol"},{"key":"1443_CR78","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4193\/Rhino16.103","volume":"55","author":"J Palm","year":"2017","unstructured":"Palm\u00a0J, Steiner\u00a0I, Abramov-Sommariva\u00a0D et\u00a0al (2017) Assessment of efficacy and safety of the herbal medicinal product BNO 1016 in chronic rhinosinusitis. Rhinology 55:142\u2013151. https:\/\/doi.org\/10.4193\/Rhino16.103","journal-title":"Rhinology"},{"key":"1443_CR79","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jaci.2016.11.014","volume":"140","author":"MM Miyake","year":"2017","unstructured":"Miyake\u00a0MM, Nocera\u00a0A, Levesque\u00a0P et\u00a0al (2017) Double-blind placebo-controlled randomized clinical trial of verapamil for chronic rhinosinusitis with nasal polyps. J\u00a0Allergy Clin Immunol 140:271\u2013273. https:\/\/doi.org\/10.1016\/j.jaci.2016.11.014","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR80","unstructured":"ClinicalTrials.gov. Zugegriffen: 18. Dez. 2023"},{"key":"1443_CR81","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.taap.2003.08.019","volume":"195","author":"Y Matsumura","year":"2004","unstructured":"Matsumura\u00a0Y, Ananthaswamy\u00a0HN (2004) Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 195:298\u2013308. https:\/\/doi.org\/10.1016\/j.taap.2003.08.019","journal-title":"Toxicol Appl Pharmacol"},{"key":"1443_CR82","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jaci.2004.11.005","volume":"115","author":"AI Koreck","year":"2005","unstructured":"Koreck\u00a0AI, Csoma\u00a0Z, Bodai\u00a0L et\u00a0al (2005) Rhinophototherapy: a\u00a0new therapeutic tool for the management of allergic rhinitis. J\u00a0Allergy Clin Immunol 115:541\u2013547. https:\/\/doi.org\/10.1016\/j.jaci.2004.11.005","journal-title":"J Allergy Clin Immunol"},{"key":"1443_CR83","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jphotobiol.2012.09.012","volume":"117","author":"IB N\u00e9meth","year":"2012","unstructured":"N\u00e9meth\u00a0IB, Zs\u00edros\u00a0O, Koreck\u00a0A et\u00a0al (2012) Ultraviolet light and photodynamic therapy induce apoptosis in nasal polyps. J\u00a0Photochem Photobiol B Biol 117:179\u2013184. https:\/\/doi.org\/10.1016\/j.jphotobiol.2012.09.012","journal-title":"J Photochem Photobiol B Biol"},{"key":"1443_CR84","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jphotobiol.2017.09.022","volume":"176","author":"\u00c1 Kiricsi","year":"2017","unstructured":"Kiricsi \u00c1, Tiszlavicz\u00a0L, R\u00e1zga\u00a0Z et\u00a0al (2017) Prospective, multicenter, randomized clinical study to evaluate the clinical efficacy and tolerability of long term mixed ultraviolet and visible light phototherapy in eosinophil nasal polyps. J\u00a0Photochem Photobiol B Biol 176:118\u2013123. https:\/\/doi.org\/10.1016\/j.jphotobiol.2017.09.022","journal-title":"J Photochem Photobiol B Biol"},{"key":"1443_CR85","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11845-021-02518-1","volume":"191","author":"\u00c1 Kiricsi","year":"2022","unstructured":"Kiricsi \u00c1, Kiricsi\u00a0M, Szab\u00f3\u00a0Z et\u00a0al (2022) Open, prospective, multicenter study on postoperative intranasal phototherapy in nasal polyposis. Irish J Med Sci 191:375\u2013383. https:\/\/doi.org\/10.1007\/s11845-021-02518-1","journal-title":"Irish J Med Sci"},{"key":"1443_CR86","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4193\/rhin16.063","volume":"55","author":"N Dulguerov","year":"2017","unstructured":"Dulguerov\u00a0N, Guinand\u00a0N, Courvoisier\u00a0D et\u00a0al (2017) Rhinophototherapy in chronic rhinosinusitis: a\u00a0double blind randomized placebo-controlled trial. Rhinol\u00a0J 55:106\u2013112. https:\/\/doi.org\/10.4193\/rhin16.063","journal-title":"Rhinol J"},{"key":"1443_CR87","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1582-4934.2008.00442.x","volume":"14","author":"D Mitchell","year":"2010","unstructured":"Mitchell\u00a0D, Paniker\u00a0L, Sanchez\u00a0G et\u00a0al (2010) Molecular response of nasal mucosa to therapeutic exposure to broad-band ultraviolet radiation. J\u00a0Cell Mol Med 14:313\u2013322. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00442.x","journal-title":"J Cell Mol Med"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-024-01443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-024-01443-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-024-01443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T18:03:33Z","timestamp":1711130613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-024-01443-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1007\/s00106-024-01443-w","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"6 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0B\u00f6scke: Potenzielle Interessenskonflikte durch Vortrags- und Beraterhonorare sowie Reisekostenerstattungen: Allergopharma, GSK, Novartis, Sanofi-Genzyme.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}